Nevada Institute of Personalized Medicine News
The Nevada Institute of Personalized Medicine (NIPM) is working to improve individual and systemic health care through translational clinical scientific research, education and workforce training, commercialization of technologies, and job creation.
Current Nevada Institute of Personalized Medicine News
Professor Marty Schiller talks about his business and how UNLV made it possible.
A collection of news stories and highlights featuring UNLV students and faculty.
News stories from the summer featuring UNLV students and faculty.
UNLV study pinpoints 10 bacterial groups associated with Alzheimer’s disease, provides new insights into the relationship between gut makeup and dementia.
Researchers track and compare wastewater samples between the Las Vegas Strip and the local community to better estimate visitor impacts to local disease trends.
UNLV infectious disease expert Edwin Oh on the potential role of wastewater surveillance and interagency, cross-jurisdictional collaboration in preventing another pandemic.
Nevada Institute of Personalized Medicine In The News
Levels of the chlamydia-causing microbe in Las Vegas wastewater increased following holidays and major events, according to an analysis presented Sunday at ASM Microbe. Wastewater surveillance has been used to track changes in the prevalence of SARS-CoV-2 and increasingly other pathogens like influenza and RSV to inform public health officials about the state of infectious disease in the community.
The Superbug, known for its resistance to anti-fungal medications has been found in elevated levels in our city's wastewater. Back in January, the Nevada Department of Health and Human Services reported the highest number of cases we have seen in Southern Nevada. We talked to the doctor who is leading waste water monitoring here in the valley to find out more about this alarming trend, along with patients hearing about the risks.
When Martin Schiller decided to launch his own company based off the research he did at UNLV, he picked Las Vegas despite the prospect of being one of only a handful of biotechnology firms in the valley.
Contrary to what many people think, there are only about 2,000 medicines approved by the Federal Drug Administration for people. And a quarter of those are biological products, or “biologics,” including vaccines, gene therapy, tissues and similar medicines—like insulin, for example.
Chastened by a series of economic downturns that punished the hospitality industry, state leaders are working to broaden the economy.
COVID-19’s latest variant is on the loose, but local experts think vaccines can mitigate its spread and severity.
